Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $109M | $446M | $5.58B | $4.83B | $3.27B | $896.00B |
| Revenue (TTM) | $60M | $137M | $1.37B | $826M | $618M | $280.33B |
| Net Income (TTM) | $7M | $43M | $475M | $254M | $-398M | $57.05B |
| Gross Margin | 67.8% | 69.7% | 77.3% | 71.8% | 4.5% | 60.0% |
| Operating Margin | 16.2% | 41.4% | 43.8% | 37.5% | -85.4% | 25.9% |
| Forward P/E | 15.4x | 10.5x | 11.5x | 16.5x | 10.9x | 14.4x |
| Total Debt | $213M | $0.00 | $935M | $22M | $641M | $942.38B |
| Cash & Equiv. | $53M | $245M | $667M | $1.08B | $380M | $343.34B |
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Bank7 Corp. (BSVN) | 100 | 428.0 | +328.0% |
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| First Financial Ban… (FFIN) | 100 | 116.5 | +16.5% |
| Simmons First Natio… (SFNC) | 100 | 131.6 | +31.6% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV ranks third and is worth considering specifically for stability.
- Beta 0.21 vs JPM's 0.94, lower leverage
BSVN carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.64, current ratio 502.78x
- PEG 0.61 vs FFIN's 3.67
- Beta 0.64, yield 2.1%, current ratio 502.78x
- NIM 4.5% vs JPM's 2.2%
HOMB is the clearest fit if your priority is income & stability.
- Dividend streak 15 yrs, beta 0.66, yield 2.8%
FFIN is the clearest fit if your priority is growth exposure.
- Rev growth 11.7%, EPS growth 13.5%
- 11.7% NII/revenue growth vs SFNC's -56.7%
SFNC is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 3.8% yield, 14-year raise streak, vs HOMB's 2.8%
- +23.0% vs FFIN's -5.5%
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs BSVN's 169.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.7% NII/revenue growth vs SFNC's -56.7% | |
| Value | Lower P/E (10.5x vs 14.4x), PEG 0.61 vs 0.81 | |
| Quality / Margins | Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs JPM's 0.94, lower leverage | |
| Dividends | 3.8% yield, 14-year raise streak, vs HOMB's 2.8% | |
| Momentum (1Y) | +23.0% vs FFIN's -5.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs SFNC's 0.9% |
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOMB leads in 1 of 6 categories
FFIN leads 1 • JPM leads 1 • PROV leads 0 • BSVN leads 0 • SFNC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. HOMB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to SFNC's -64.3%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $60M | $137M | $1.4B | $826M | $618M | $280.3B |
| EBITDAEarnings before interest/tax | $12M | $58M | $618M | $320M | -$444M | $81.4B |
| Net IncomeAfter-tax profit | $7M | $43M | $475M | $254M | -$398M | $57.0B |
| Free Cash FlowCash after capex | $9M | $36M | $311M | $283M | $410M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +67.8% | +69.7% | +77.3% | +71.8% | +4.5% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +41.4% | +43.8% | +37.5% | -85.4% | +25.9% |
| Net MarginNet income ÷ Revenue | +11.0% | +31.4% | +34.6% | +30.7% | -64.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | +15.3% | +26.4% | +22.6% | +34.3% | +66.4% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | -3.4% | +26.0% | -7.7% | +42.1% | +16.0% |
Valuation Metrics
Evenly matched — BSVN and SFNC each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 10.3x trailing earnings, BSVN trades at a 46% valuation discount to FFIN's 19.0x P/E. Adjusting for growth (PEG ratio), BSVN offers better value at 0.61x vs FFIN's 4.22x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $109M | $446M | $5.6B | $4.8B | $3.3B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $269M | $202M | $5.9B | $3.8B | $3.5B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 10.33x | 11.72x | 19.01x | -7.63x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 10.46x | 11.47x | 16.54x | 10.90x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.61x | 0.89x | 4.22x | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 21.77x | 3.48x | 9.47x | 11.79x | — | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 3.25x | 4.06x | 5.85x | 5.21x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.90x | 1.77x | 1.30x | 2.52x | 0.89x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 10.78x | 11.58x | 15.72x | 7.73x | 8.88x |
Profitability & Efficiency
FFIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BSVN delivers a 18.2% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-11 for SFNC. FFIN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), FFIN scores 8/9 vs SFNC's 4/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +18.2% | +11.4% | +14.2% | -11.5% | +15.9% |
| ROA (TTM)Return on assets | +0.5% | +2.3% | +2.1% | +1.7% | -1.6% | +1.3% |
| ROICReturn on invested capital | +1.9% | +18.3% | +8.7% | +12.4% | -9.1% | +4.5% |
| ROCEReturn on capital employed | +2.4% | +5.2% | +11.5% | +16.6% | -4.2% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 8 | 4 | 5 |
| Debt / EquityFinancial leverage | 1.66x | — | 0.22x | 0.01x | 0.19x | 2.60x |
| Net DebtTotal debt minus cash | $160M | -$245M | $268M | -$1.1B | $261M | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $245M | $667M | $1.1B | $380M | $343.3B |
| Total DebtShort + long-term debt | $213M | $0 | $935M | $22M | $641M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.39x | 1.47x | 1.54x | -1.01x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BSVN five years ago would be worth $28,907 today (with dividends reinvested), compared to $7,409 for FFIN. Over the past 12 months, SFNC leads with a +23.0% total return vs FFIN's -5.5%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs FFIN's 7.5% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +13.0% | +2.7% | +13.5% | +20.7% | -0.5% |
| 1-Year ReturnPast 12 months | +14.5% | +20.3% | +3.0% | -5.5% | +23.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +50.9% | +97.2% | +31.2% | +24.3% | +37.1% | +138.2% |
| 5-Year ReturnCumulative with dividends | +18.2% | +189.1% | +22.1% | -25.9% | -11.5% | +118.2% |
| 10-Year ReturnCumulative with dividends | +25.8% | +169.2% | +57.7% | +136.4% | +26.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +25.4% | +9.5% | +7.5% | +11.1% | +33.6% |
Risk & Volatility
Evenly matched — PROV and SFNC each lead in 1 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SFNC currently trades 99.5% from its 52-week high vs FFIN's 86.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.64x | 0.66x | 0.78x | 0.89x | 0.94x |
| 52-Week HighHighest price in past year | $17.42 | $50.10 | $30.83 | $38.74 | $22.62 | $337.25 |
| 52-Week LowLowest price in past year | $14.95 | $37.56 | $25.50 | $28.11 | $17.00 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +92.8% | +91.6% | +86.9% | +99.5% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 62.6 | 63.7 | 61.3 | 63.7 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 11K | 1.4M | 683K | 1.1M | 7.0M |
Analyst Outlook
Evenly matched — HOMB and FFIN and SFNC and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", BSVN as "Buy", HOMB as "Hold", FFIN as "Hold", SFNC as "Buy", JPM as "Buy". Consensus price targets imply 22.6% upside for BSVN (target: $57) vs -6.5% for PROV (target: $16). For income investors, SFNC offers the higher dividend yield at 3.79% vs JPM's 1.86%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $16.00 | $57.00 | $31.50 | $39.25 | $23.00 | $339.75 |
| # AnalystsCovering analysts | 10 | 3 | 19 | 15 | 9 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +2.1% | +2.8% | +2.2% | +3.8% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 7 | 15 | 15 | 14 | 15 |
| Dividend / ShareAnnual DPS | $0.56 | $0.98 | $0.80 | $0.74 | $0.85 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +0.3% | +1.5% | 0.0% | 0.0% | +3.9% |
HOMB leads in 1 of 6 categories (Income & Cash Flow). FFIN leads in 1 (Profitability & Efficiency). 3 tied.
PROV vs BSVN vs HOMB vs FFIN vs SFNC vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or BSVN or HOMB or FFIN or SFNC or JPM a better buy right now?
For growth investors, First Financial Bankshares, Inc.
(FFIN) is the stronger pick with 11. 7% revenue growth year-over-year, versus -56. 7% for Simmons First National Corporation (SFNC). Bank7 Corp. (BSVN) offers the better valuation at 10. 3x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Bank7 Corp. (BSVN) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
On trailing P/E, Bank7 Corp.
(BSVN) is the cheapest at 10. 3x versus First Financial Bankshares, Inc. at 19. 0x. On forward P/E, Bank7 Corp. is actually cheaper at 10. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank7 Corp. wins at 0. 61x versus First Financial Bankshares, Inc. 's 3. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
Over the past 5 years, Bank7 Corp.
(BSVN) delivered a total return of +189. 1%, compared to -25. 9% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 357% more volatile than PROV relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
By revenue growth (latest reported year), First Financial Bankshares, Inc.
(FFIN) is pulling ahead at 11. 7% versus -56. 7% for Simmons First National Corporation (SFNC). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -343. 8% for Simmons First National Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 34. 6% net margin versus -63. 4% for Simmons First National Corporation — meaning it keeps 34. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 43. 8% versus -84. 2% for SFNC. At the gross margin level — before operating expenses — HOMB leads at 77. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or BSVN or HOMB or FFIN or SFNC or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank7 Corp. (BSVN) is the more undervalued stock at a PEG of 0. 61x versus First Financial Bankshares, Inc. 's 3. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank7 Corp. (BSVN) trades at 10. 5x forward P/E versus 16. 5x for First Financial Bankshares, Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BSVN: 22. 6% to $57. 00.
08Which pays a better dividend — PROV or BSVN or HOMB or FFIN or SFNC or JPM?
All stocks in this comparison pay dividends.
Simmons First National Corporation (SFNC) offers the highest yield at 3. 8%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is PROV or BSVN or HOMB or FFIN or SFNC or JPM better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, SFNC: +26. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and BSVN and HOMB and FFIN and SFNC and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; BSVN is a small-cap deep-value stock; HOMB is a small-cap deep-value stock; FFIN is a small-cap quality compounder stock; SFNC is a small-cap income-oriented stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.